Ch. du Vernay 14a
CH-Vaud
1196 Gland
info@neumarz.com
+41.21.561.34.96
Back

Reverse Termination Fees: Who Pays When a Deal Collapses

TLDR: A reverse termination fee is the price a buyer agrees to pay for the right to walk away from a signed merger agreement. Its size, anywhere from under 1% to more than 14% of deal value, tells you how much financing risk, antitrust risk, and plain execution risk the seller managed to push back onto the acquirer. Negotiating this single number, and the conditions that trigger it, is one of the highest-leverage moments in any cross-border transaction.

The Fee That Runs in the Other Direction

Most executives are familiar with the ordinary break fee: if a target’s board changes its recommendation, or shareholders reject the deal in favor of a higher bid, the target pays the acquirer for the time and cost sunk into the process. When Microsoft agreed to acquire LinkedIn in 2016, it negotiated a $725 million breakup fee payable by LinkedIn under exactly those circumstances. That fee protects the buyer.

A reverse termination fee protects the seller by flowing in the opposite direction. The buyer, not the target, pays if the deal fails for reasons within the buyer’s sphere: financing collapses, regulators block the transaction, or the acquirer simply refuses to close. Sellers accept the risk of losing a deal partner; reverse termination fees compensate them for taking on a buyer whose ability to close is never fully guaranteed at signing.

Two Failure Modes Dominate the Drafting

Financing failure and regulatory failure account for the overwhelming majority of reverse termination fee triggers. Financing risk is concentrated in private-equity-led deals, where the buyer depends on debt commitments that can evaporate between signing and closing. Regulatory risk shows up whenever the transaction draws antitrust scrutiny, and it is far from a marginal concern: research from NYU law professor Edward Rock found that roughly two-thirds of deals that received a second request for information from US antitrust regulators carried a reverse termination fee, with nearly all of those fees tied to the passing of a contractual “end date” rather than to a fixed calendar deadline.

That end-date structure matters more than it looks. It gives both sides an incentive to keep working toward clearance up to the wire, while giving the seller a hard trigger the moment the buyer’s regulatory efforts run out of road. Sellers with real leverage increasingly pair the fee with a “hell or high water” covenant that obliges the buyer to divest assets if that is what antitrust approval requires, narrowing the buyer’s room to claim it tried and failed.

How Large the Number Actually Gets

Reverse termination fees vary enormously by deal type, buyer profile, and regulatory exposure. Bloomberg Law’s review of 78 publicly filed agreements for US targets valued at $5 billion or more, announced between January 2020 and mid-July 2022, found fees ranging from 0.3% to 15% of total deal value. Regulatory reverse termination fees in that sample averaged 3.5% of deal value; non-regulatory fees, covering financing failure and outright walk-aways, averaged a higher 4.8%. For scale, the reverse termination fee in the 2022 agreement for Elon Musk’s attempted acquisition of Twitter was $1 billion, equal to 2.3% of the deal’s total value, which placed it on the lower end of that year’s range.

Financial buyers face a structurally different calculus than strategic acquirers. A Houlihan Lokey study of 126 public targets, cited in Wall Street Prep’s overview of the mechanic, found that a reverse termination fee appeared in only 41% of deals with a strategic buyer, compared with 83% of deals with a private equity buyer, and that the fee averaged 6.5% of target enterprise value for financial buyers against 3.7% for strategic ones. The gap exists because financing risk is real and priced accordingly: when Verizon Communications bought out Vodafone’s stake in Verizon Wireless in 2014, it agreed to a reverse termination fee of $10 billion tied specifically to its ability to secure financing for the purchase.

Fee type Who pays Typical size (% of deal value) Common trigger
Ordinary break fee Target / seller 1% to 5% Board changes recommendation; competing bid accepted
Reverse termination fee, regulatory Acquirer / buyer Averaged 3.5%; observed range 1.6% to 15% Antitrust or regulatory approval not obtained by the end date
Reverse termination fee, non-regulatory Acquirer / buyer Averaged 4.8%; observed range 0.3% to 15% Financing failure, shareholder vote failure, willful breach

When the Fee Becomes the Fight Itself

The theory is tidy: the fee sits in the agreement, and if the deal fails for a covered reason, the buyer writes a check. In practice, the fee often becomes the very thing the parties end up litigating. The 2022 agreement between Kroger and Albertsons included a $600 million fee payable if the merger collapsed once every closing condition other than regulatory approval had been satisfied. Courts blocked the deal in December 2024, Kroger terminated the agreement, and rather than a clean payout, Albertsons sued Kroger, arguing the termination amounted to a willful breach that entitled it to damages beyond the fee itself, while Kroger contended it owed nothing because Albertsons had failed to meet its own covenants. The dispute illustrates the limit of drafting: a reverse termination fee only allocates risk cleanly if the trigger language is precise enough that neither side can plausibly argue the other one caused the failure.

Structuring the Fee as a Negotiating Instrument

Sophisticated sellers no longer treat the reverse termination fee as a single blunt number. Two-tier structures are now common: a smaller fee for regulatory failure, reflecting the reality that antitrust outcomes are partly outside either party’s control, and a larger fee for financing failure or a straightforward change of heart, where the buyer bears more direct responsibility. Pairing the fee with a specific performance clause, which lets the seller sue to force the buyer to draw down committed financing rather than simply pay and walk, has become close to standard practice in private-equity-led acquisitions, shifting leverage further toward the seller without raising the headline fee at all.

The drop-dead date deserves the same scrutiny as the percentage. A short end date favors the seller by triggering the fee sooner if regulatory clearance stalls; a longer one gives a buyer facing a complex antitrust review more room to work without forfeiting the deal. Both figures, the fee and the date, should be negotiated together rather than in sequence, because a generous fee attached to an unrealistically short end date can end up protecting nobody.

Getting the Number Right Before It Is Tested

Every reverse termination fee is, in effect, a bet on how the deal might fail. Sellers who price financing risk, antitrust risk, and buyer commitment accurately at signing rarely end up in the kind of dispute that consumed Kroger and Albertsons. Getting there requires modelling the buyer’s actual financing structure, the realistic antitrust timeline for the specific industry, and the precedent set by comparable transactions, not just importing a market-average percentage.

Neumarz advises boards and sponsors on exactly this calculus: sizing reverse termination and break fees against deal-specific risk, structuring end dates and specific performance provisions that hold up under stress, and stress-testing the language before signing rather than after a deal collapses. Deal-certainty terms are negotiated once, at the moment of maximum leverage, and Neumarz’s role is to make sure that moment is used well.

References

  1. Bloomberg Law, “ANALYSIS: How Wide Can Reverse Termination Fees Range in Deals?” https://news.bloomberglaw.com/bloomberg-law-analysis/analysis-how-wide-can-reverse-termination-fees-range-in-deals
  2. Wall Street Prep, “Breakup Fees and Reverse Termination Fees in M&A” https://www.wallstreetprep.com/knowledge/break-fees-reverse-termination-fees-ma/
  3. Analysis Group, “The Use of Reverse Termination Fees in Merger Reviews” (Q&A with Prof. Edward Rock, NYU School of Law) https://www.analysisgroup.com/Insights/ag-feature/q-and-a/the-use-of-reverse-termination-fees-in-merger-reviews/
  4. Harvard Law School Forum on Corporate Governance, “Practice Points Arising from Albertsons’ Claims Against Kroger for Breach of their Merger Agreement” https://corpgov.law.harvard.edu/2025/01/21/practice-points-arising-from-albertsons-claims-against-kroger-for-breach-of-their-merger-agreement/

Leave a Reply

Your email address will not be published. Required fields are marked *

Legal Disclaimer

Investments involve a high degree of risk.

Investors should carefully consider the risks described & all other information in the investor agreement provided to you before deciding whether to invest in the proposal.

Participation and investment are speculative activities that involve a high degree of financial risk. Certain risk factors that should be considered in assessing an investment in Neumarz (an Allegory Capital & Kainjoo SA brand) and its activities include, but are limited to, those set out below.

Any one or more of these risks could have a material adverse effect on the value of any investment in Neumarz, an Allegory Capital & Kainjoo SA brand, and the business, financial position or operating results of Neumarz, an Allegory Capital & Kainjoo SA brand.

An investor may lose all or part of his or her investment in Neumarz, an Allegory Capital & Kainjoo SA brand.

Additional risks and uncertainties not currently known to the officers and directors of Neumarz, an Allegory Capital & Kainjoo SA brand, may also adversely affect current activities. The information below is not an exhaustive summary of the risks affecting Neumarz, an Allegory Capital & Kainjoo SA brand. It is not intended to be presented in any assumed order of priority. The hazards relating to the business of Neumarz, an Allegory Capital & Kainjoo SA brand, include, among other things:

(a) there are no assurances that Allegory Capital  or Kainjoo SA will earn profits in the future or that profitability will be sustained;

(b) there are no assurances that Allegory Capital  or Kainjoo SA will have access to sufficient funding for future operations or to fulfil its obligations under current agreements;

(c) risks that are inherent to investments, including (i) the valuation of these assets is subject to significant volatility, (ii) the regulatory regime governing venture capital investments is uncertain, and new regulations or policies may materially adversely affect the development of investment, (iii) the further development of businesses are subject to a variety of factors that are difficult to evaluate, (iv) companies and intangible assets are at risk of security breaches, (v) potential loss or destruction due to cybersecurity threats, and (vi) risks of an illiquid market for assets;

(d) difficulty in valuing investments;

(e) Allegory Capital and Kainjoo SA have limited operating history, and there is no assurance that the investments of Allegory Capital will be profitable;

(f) Allegory Capital has not generated revenues to date, and there can be no guaranteed return on its investments;

(g) directors, officers and key employees may resign from Allegory Capital ;

(h) Allegory Capital is unable to insure against every risk to which it is exposed;

(i) Laws relating to the business of Allegory Capital may be changed in a manner which adversely affects Allegory Capital ;

(j) Allegory Capital may invest in entities with no operating history, making evaluating such entities complex and

(k) Risk related to foreign exchange rates.

Additional risks and uncertainties not presently known to Allegory Capital and Kainjoo SA or that it currently deems immaterial may substantially affect its business, financial condition, valuations, trading performance and prospects.

Potential investors are accordingly advised to consult an independent financial adviser who specializes in advising on investments of this kind before making any investment decisions in Allegory Capital or Kainjoo SA.

A prospective investor should consider whether an investment in Allegory Capital or Kainjoo SA is suitable in light of his or her circumstances and the available financial resources.